PFIZER - Technical Analysis with Chart Patterns & Indicators

Last Updated Time : 05 Nov 25, 7:43 am

Technical Rating: 3.7

📊 Technical Analysis Summary

• Trend Status: Consolidating with mild bullish bias
• Current Price: ₹5,215
• RSI (46.0): Neutral zone — no strong momentum
• MACD (22.6): Bullish crossover — early upward signal
• Volume: Slightly above average (12.1K vs 11.5K) — stable interest
• DMA 50/200: Price above 200 DMA but below 50 DMA — mixed signals
• Bollinger Bands: Price near mid-band — no breakout yet

📈 Entry & Exit Zones

• Support Levels: ₹5,100 / ₹4,950 / ₹4,800
• Resistance Levels: ₹5,250 / ₹5,400 / ₹5,600
• Optimal Entry: ₹5,100–₹5,200 (on dip near support)
• Exit Target: ₹5,400–₹5,600 (if momentum improves)

✅ Positive

• MACD crossover suggests early bullish momentum
• Low debt-to-equity ratio (0.01) — strong financial discipline
• ROCE (21.6%) and ROE (16.4%) — solid operational efficiency

⚠️ Limitation

• Price below 50 DMA — short-term weakness
• RSI in neutral zone — no strong momentum
• High PEG ratio (22.4) — expensive relative to growth

📉 Company Negative News

• DII holding declined by 0.12% — slight domestic investor caution
• Quarterly PAT dipped from ₹198 Cr to ₹192 Cr — minor decline

📈 Company Positive News

• FII holding increased by 0.20% — foreign investor interest
• EPS of ₹177 and consistent dividend payout — shareholder value

🏢 Industry

• PFIZER operates in pharmaceuticals — defensive and stable sector
• Industry P/E is 33.1 vs PFIZER’s 35.4 — slightly overvalued
• Sector benefits from healthcare demand and innovation cycles

🧾 Conclusion

• PFIZER is currently consolidating with early signs of bullish momentum
• Entry near ₹5,100–₹5,200 may offer upside toward ₹5,400–₹5,600
• Fundamentals remain strong — suitable for medium-term accumulation